Greeting
Since our founding in 2000,
we have pursued one guiding principle: “Discover the answers in nature.”
Our team is dedicated to providing safe and sustainable immune solutions for both
humans and animals through the development of yolk immunoglobulin (IgY)—a natural alternative to chemical agents and antibiotics.
By successfully commercializing IgY, we have taken a meaningful step toward overcoming
the limitations of conventional treatments and have earned recognition in domestic and global markets alike.
We will continue to drive research, innovation, and responsible biotechnology to safeguard the health of livestock, aquaculture species,
and companion animals—while contributing to a healthier environment for all.
Thank you for your continued interest and support.
With increasing global regulations due to antibiotic-resistant bacteria and antibiotic residues in food,
we develop and produce IgY-based immune antibodies as a safe and nature-friendly alternative,
contributing to the improvement of animal health.
In the IgY (Yolk Immunoglobulin) field, applicable to food, feed, cosmetics, diagnostic kits, and pharmaceuticals,
we research and produce IgY targeting pathogenic bacteria and viruses,
and expand domestic and global markets based on high-titer antibody manufacturing and large-scale purification technology.
Focusing on skin barrier issues in atopic skin and toxins from Staphylococcus aureus,
we develop animal-derived moisturizers and offer products with proven efficacy through
MFDS-approved safety evaluations and professional clinical testing.